Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F66W4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,575
Award facts
- Contract value 100% obligated
- $17,575.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,575.15 to Amerisourcebergen Drug Corp for the supply of Xarelto 20 mg tablets (90-count units) on January 27, 2026, with an ultimate completion date of January 28, 2026. This is a firm fixed-price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling Amerisourcebergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor providing essential medical products to federal government agencies. The parent company, Cencora, maintains a significant IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031. Both entities have demonstrated their capability to meet federal procurement requirements through open competition, consistently securing non-set-aside contracts with firm fixed-price structures. Their federal contract portfolio demonstrates extensive experience supplying critical pharmaceutical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F66W4?
SPE2DR26F66W4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F66W4 worth?
The government has obligated $17,575 on SPE2DR26F66W4.
Is contract SPE2DR26F66W4 an order under another contract?
Yes. SPE2DR26F66W4 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66W4 competed?
The extent of competition for SPE2DR26F66W4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award